CONCLUSIONS: 25% of newly diagnosed ADHD adults received no treatment in 2021 and 53.7% only received a single-modality treatment – raising concerns about the potential implications of untreated ADHD on the persistence of ADHD-related impairments, morbidity, productivity, and downstream healthcare cost. The study also highlighted potential sociodemographic, clinical, and provider disparities in ADHD treatment.
